The liver during and after fulminant hepatitis

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Fulminant hepatitis is a severe liver condition with high mortality.
• Understanding the long-term consequences of fulminant hepatitis is crucial for patient management.

Purpose of the Study:

• To investigate the histological outcomes and long-term sequelae in patients recovering from fulminant hepatitis.
• To explore the relationship between acute liver injury and the development of chronic liver disease.

Main Methods:

• Liver biopsies were performed during the acute phase (5-14 days post-coma onset) in 14 patients.
• Follow-up liver biopsies were obtained 6-60 months post-recovery in 9 patients.
• Autopsies were conducted in 2 patients who died from complications.

Main Results:

• Acute biopsy findings included multilobular necrosis (4 patients), confluent necrosis (9 patients), and portal inflammation (1 patient).
• Coma severity did not correlate with necrosis severity.
• Three of nine patients who had follow-up biopsies developed chronic active hepatitis, with one progressing to cirrhosis.

Conclusions:

• Fulminant hepatitis, potentially driven by immune attack, can result in chronic liver disease.
• The process may not always eradicate hepatitis B surface antigen or prevent chronic hepatitis or cirrhosis.
• Long-term monitoring is essential for patients recovering from severe acute liver injury.